Brubaker, L, Richter, HE, Barber, MD, Hsu, Y, Rahn, DD, Menefee, S, Visco, A, Spino, C, Martin, S, and Meikle, SF. "Pelvic floor disorders clinical trials: participant recruitment and retention." International urogynecology journal 24, no. 1 (January 2013): 73-79.
Anthony Gabriele Visco, MD
Robotic sacrocolpopexy, robotic hysterectomy, outcomes for surgical and non-surgical treatments of urinary incontinence and pelvic organ prolapse, robotic surgery, mesh erosion, Botox therapy for urge incontinence.
Education and Training
- Resident, Obstetrics & Gynecology, University of Rochester, 1993 - 1997
- M.D., SUNY Upstate Medical University, 1993
Selected Grants and Awards
- Building Interdisciplinary Research Careers in Women's Health
- NICHD Pelvic Floor Disorders Network (PFDN)
- Duke University Medical Center (DUMC) Pelvic Floor Disorders Network (PFDN) Clinical Site
- Duke KURe Program
- Combination Therapy in the Treatment of Urge Urinary Incontinence: A Randomized, Placebo Controlled Trial
- Translational Research in Pelvic Floor Disorders
- Genetic Epidemiology of Pelvic Organ Prolapse
- Molecular and biochemical Study of Collagen in Prolapse
Jonsson Funk, M, Edenfield, AL, Pate, V, Visco, AG, Weidner, AC, and Wu, JM. "Trends in use of surgical mesh for pelvic organ prolapse." Am J Obstet Gynecol 208, no. 1 (January 2013): 79.e1-79.e7.
Visco, AG, Brubaker, L, Richter, HE, Nygaard, I, Paraiso, MFR, Menefee, SA, Schaffer, J, Lowder, J, Khandwala, S, Sirls, L, Spino, C, Nolen, TL, Wallace, D, Meikle, SF, and Pelvic Floor Disorders Network, . "Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence." N Engl J Med 367, no. 19 (November 8, 2012): 1803-1813.
Levin, PJ, Visco, AG, Shah, SH, Fulton, RG, and Wu, JM. "Characterizing the phenotype of advanced pelvic organ prolapse." Female Pelvic Med Reconstr Surg 18, no. 5 (September 2012): 299-302.
Wu, JM, Visco, AG, Grass, EA, Craig, DM, Fulton, RG, Haynes, C, Weidner, AC, and Shah, SH. "Matrix metalloproteinase-9 genetic polymorphisms and the risk for advanced pelvic organ prolapse." Obstet Gynecol 120, no. 3 (September 2012): 587-593.
Wu, JM, Visco, AG, Grass, EA, Craig, DM, Fulton, RG, Haynes, C, Amundsen, CL, and Shah, SH. "Comprehensive analysis of LAMC1 genetic variants in advanced pelvic organ prolapse." Am J Obstet Gynecol 206, no. 5 (May 2012): 447.e1-447.e6.
Siddiqui, NY, Geller, EJ, and Visco, AG. "Symptomatic and anatomic 1-year outcomes after robotic and abdominal sacrocolpopexy." Am J Obstet Gynecol 206, no. 5 (May 2012): 435.e1-435.e5.
Dieter, AA, Amundsen, CL, Visco, AG, and Siddiqui, NY. "Treatment for urinary tract infection after midurethral sling: a retrospective study comparing patients who receive short-term postoperative catheterization and patients who pass a void trial on the day of surgery." Female Pelvic Med Reconstr Surg 18, no. 3 (May 2012): 175-178.
Visco, AG, Brubaker, L, Richter, HE, Nygaard, I, Paraiso, MF, Menefee, SA, Schaffer, J, Wei, J, Chai, T, Janz, N, Spino, C, Meikle, S, and Pelvic Floor Disorders Network, . "Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial." Contemp Clin Trials 33, no. 1 (January 2012): 184-196.
Brubaker, L, Barber, MD, Nygaard, I, Nager, CW, Varner, E, Schaffer, J, Visco, A, Meikle, S, Spino, C, and Pelvic Floor Disorders Network, . "Quantification of vaginal support: are continuous summary scores better than POPQ stage?." American journal of obstetrics and gynecology 203, no. 5 (November 2010): 512.e1-512.e6.